This inventor holds 1 USPTO granted patent. Top assignee: Istituto Superiore Di Sanita. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Stefano Maria Santini
Introduction
Stefano Maria Santini is a notable inventor based in Rome, Italy. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the generation of highly active human dendritic cells, which play a crucial role in the immune response.
Latest Patents
Stefano Maria Santini holds a patent for a "Method for generating highly active human dendritic cells from peripheral blood mononuclear cells." This invention relates to a process for deriving dendritic cells from mononuclear cells in culture. The method involves contacting type I IFN with the mononuclear cells, resulting in dendritic cells that can be used as cellular adjuvants in both prophylactic and therapeutic vaccinations for animals and humans. The process is efficient, allowing for the generation of these cells after a single-step treatment in a brief period of time. Additionally, the patent includes pharmaceutical compositions that incorporate these dendritic cells, particularly vaccines that utilize them as an active principle.
Career Highlights
Stefano Maria Santini is affiliated with the Istituto Superiore di Sanità, where he continues to advance his research in immunology. His work has implications for the treatment of various pathologies associated with the presence of antigens in human beings.
Collaborations
Some of his notable coworkers include Laura Santodonato and Stefania Parlato, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Stefano Maria Santini's innovative work in generating dendritic cells represents a significant advancement in immunological research. His contributions have the potential to enhance vaccination strategies and improve therapeutic outcomes for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
